Journal of Advances in Clinical Nursing
Journal of Advances in Clinical Nursing. 2023; 2: (5) ; 10.12208/j.jacn.20230209 .
总浏览量: 268
新疆喀什地区第二人民医院 新疆喀什
*通讯作者： 赵文梅,单位：新疆喀什地区第二人民医院 新疆喀什；
目的 探讨在经静脉泵入血管活性药物中应用护理安全管理方法和干预措施的影响。方法 确定研究时间，2021年10月至2022年10月时段，入我院接受经静脉泵入血管活性药物患者中抽取60例，以上的患者接受双盲法均分，各30例。对比组（常规护理），分析组（护理安全管理方法和干预措施），对比两组患者相关指标、不良事件、护理满意度进行分析。结果 分析组相关指标、不良事件、护理满意度都优于对比组（p＜0.05）。结论 目前在经静脉泵入血管活性药物临床治疗中，护理措施十分必要，其中护理安全管理方法和干预措施从长期看效果更好，具有其独特优势，能够帮助患者改善身体状态，应在该领域广泛应用。
Objective To explore the effect of nursing safety management and intervention measures in the treatment of vasoactive drugs by intravenous pump. Methods the study period was 2021 from October to October 2022. Sixty patients were enrolled in the study and divided into two groups. Comparison Group (routine nursing) , Analysis Group -LRB-nursing safety management methods and interventions) , comparison of the two groups of patients-related indicators, adverse events, nursing satisfaction were analyzed. Results the related indexes, adverse events and nursing satisfaction in the analysis group were better than those in the control group (p < 0.05) . Conclusion At present, nursing measures are very necessary in the clinical treatment of vasoactive drugs pumped through vein, among which the nursing safety management method and intervention measures are more effective in the long term and have their unique advantages, can help patients improve their physical state, should be widely used in this field.
[1] 汪徽,钱晓英. 集束化护理在重症患者输注血管活性药物中的应用[J]. 中外女性健康研究,2022(5):121-123.
[2] 李立青,马嘉琳. 心电监护下微量泵输入多种血管活性药物治疗重症心力衰竭的临床护理观察[J]. 中国医药科学,2022,12(6):105-108.
[3] 杜娟,余静,王琳. 集束化护理在危重症患者血管活性药物使用管理中的应用观察[J]. 贵州医药, 2021, 45(11): 1829-1830.
[4] 夏静,代晓变,柳玉强. PDCA循环质量管理方法在老年内分泌静脉药物配置中心护理管理中的应用研究[J]. 贵州医药,2022,46(5):828-829.
[5] NI, JING BIN, XIANG, XIAO XING, WU, WEI, et al. Transjugular intrahepatic portosystemic shunt in patients treated with a balloon tamponade for variceal hemorrhage without response to high doses of vasoactive drugs: A real-world multicenter retrospective study[J]. Journal of digestive diseases,2021,22(5):236-245.
[6] 温春嫦. 针对性护理干预对外周静脉血管活性药物所致的静脉炎及患者生活质量的影响[J]. 吉林医学, 2021, 42(2): 493-494.
[7] 李静,苏云艳,伍梦雅. 护理安全管理在使用血管活性药物患者中的临床应用效果[J]. 当代护士（上旬刊）, 2021, 28(5): 187-189.
[8] 程洪涯,滕中华,黎丹洁,等. 外周静脉输注血管活性药物过程中的护理安全问题及对策[J]. 临床医学研究与实践, 2021, 6(11):148-150.
[9] MOODY, TERRY W., JENSEN, ROBERT T.. Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide (Part 2): biology and clinical importance in central nervous system and inflammatory disorders[J]. Current opinion in endocrinology, diabetes, and obesity,2021,28(2):206-213.
[10] 钟美慧,杨秀,张子涵. 针对性护理干预对外周静脉血管活性药物所致的静脉炎及患者生活质量的影响[J]. 中国保健营养,2021,31(36):154.
[11] 温春嫦. 针对性护理干预对外周静脉血管活性药物所致的静脉炎及患者生活质量的影响[J]. 吉林医学, 2021, 42(2): 493-494.